About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Pioglitazone Hydrochloride
- Company
- Gilead Sciences
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 31 recruiting
Efficacy results: Not yet reported
31 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026
Find a Clinical Trial Near Me
See recruiting studies for Pioglitazone Hydrochloride and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02889003
Second STOP After Pioglitazone Priming in CML Patients
Not yet reported Versailles Hospital 26 participants Est. completion 2028-12 6 sitesOther conditions: Chronic Myeloid Leukemia (CML)View official trial listing → -
Recruiting NCT NCT02969798
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Not yet reported The University of Texas Health Science Center at San Antonio 700 participants Est. completion 2027-07 1 siteType 2 diabetesPrediabetesView official trial listing → -
Recruiting NCT NCT03109288
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 250 participants Est. completion 2029-01-01 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Recruiting NCT NCT03866408
Insulin Regulation of Lipolysis and Lipolysis Proteins
Not yet reported Mayo Clinic 64 participants Est. completion 2026-12-31 1 siteOther conditions: ObesityView official trial listing → -
Recruiting NCT NCT04501406
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Not yet reported University of Florida 166 participants Est. completion 2027-08-31 1 siteType 2 diabetesMASHView official trial listing → -
Recruiting NCT NCT05013255
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
Not yet reported West Virginia University 30 participants Est. completion 2026-12 1 siteOther conditions: Breast Cancer, Muscle FatigueView official trial listing → -
Recruiting NCT NCT05028140
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Not yet reported EMS 480 participants Est. completion 2027-09 1 siteOther conditions: Type II DiabetesView official trial listing → -
Recruiting NCT NCT05305287
Quantifying Hepatic Mitochondrial Fluxes in Humans
Not yet reported The University of Texas Health Science Center at San Antonio 60 participants Est. completion 2027-03-31 2 sitesType 2 diabetes Other conditions: Non-Alcoholic Fatty Liver Disease, Mitochondrial Metabolism DisordersView official trial listing → -
Recruiting NCT NCT05331534
Effect of Attentional Therapy on Post-traumatic Stress Disorder
Not yet reported University Hospital, Lille 140 participants Est. completion 2029-02-02 1 siteOther conditions: Post Traumatic Stress DisorderView official trial listing → -
Recruiting NCT NCT05501483
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
Not yet reported Karolinska Institutet 60 participants Est. completion 2032-12-31 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT05705492
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Not yet reported OHSU Knight Cancer Institute 66 participants Est. completion 2027-06-30 1 siteOther conditions: Advanced Malignant Solid Neoplasm, Advanced Biliary Tract Carcinoma, Advanced Esophageal Carcinoma, Metastatic Esophageal Carcinoma, Locally Advanced Colorectal Carcinoma, Locally Advanced Esophageal Carcinoma, Locally Advanced Gastric Carcinoma, Metastatic Colorectal Carcinoma (mCRC), Advanced Lung Carcinoma, Locally Advanced Hepatocellular CarcinomaView official trial listing → -
Recruiting NCT NCT05727761
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Not yet reported University of Minnesota 36 participants Est. completion 2027-07-30 2 sitesOther conditions: Oral LeukoplakiaView official trial listing → -
Recruiting NCT NCT05753657
A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.
Not yet reported Rambam Health Care Campus 30 participants Est. completion 2027-12-31 1 siteOther conditions: Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug InducedView official trial listing → -
Recruiting NCT NCT05838287
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Not yet reported The University of Texas Health Science Center at San Antonio 78 participants Est. completion 2030-01 1 siteType 2 diabetesHeart failureView official trial listing → -
Recruiting NCT NCT05946564
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
Not yet reported Assistance Publique - Hôpitaux de Paris 126 participants Est. completion 2028-11 25 sites Stand-aloneOther conditions: ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic GlomerulonephritisView official trial listing → -
Recruiting NCT NCT06246799
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Not yet reported The University of Texas Health Science Center at San Antonio 256 participants Est. completion 2029-06-30 2 sitesType 2 diabetesView official trial listing → -
Recruiting NCT NCT06336798
Bioenergetic Effect of Pioglitazone in CLD-PH
Not yet reported Emory University 20 participants Est. completion 2028-02 1 siteOther conditions: Pulmonary Hypertension, Pulmonary Hypertension Due to Lung DiseasesView official trial listing → -
Recruiting NCT NCT06399835
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Not yet reported Seoul National University Bundang Hospital 120 participants Est. completion 2027-12-31 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT06446531
Prevention of Progression of Prediabetes, Obesity and CV Risk
Not yet reported The University of Texas Health Science Center at San Antonio 64 participants Est. completion 2027-07 1 site Stand-alonePrediabetesCardiovascular disease Other conditions: Weight, BodyView official trial listing → -
Recruiting NCT NCT06649162
A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
Boryung Pharmaceutical Co., Ltd 10000 participants Est. completion 2027-03 2 sitesType 2 diabetesView official trial listing → -
Recruiting NCT NCT06657209
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Not yet reported Stanford University 104 participants Est. completion 2027-12-15 2 sitesType 2 diabetes Other conditions: Diabetes, Pre DiabetesView official trial listing → -
Recruiting NCT NCT06729996
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus
Not yet reported Mayo Clinic 50 participants Est. completion 2027-05-31 3 sites Stand-aloneOther conditions: Pancreatitis, Chronic, Pancreatitis, Acute, Diabetes MellitusView official trial listing → -
Recruiting NCT NCT06875193
DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes
Not yet reported Dong Wha Pharmaceutical Co. Ltd. 196 participants Est. completion 2025-12-31 1 siteOther conditions: Type2diabetesView official trial listing → -
Recruiting NCT NCT06972732
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Not yet reported Boryung Pharmaceutical Co., Ltd 204 participants Est. completion 2026-10-01 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT06989723
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Not yet reported Seoul National University Bundang Hospital 120 participants Est. completion 2027-06-30 1 site Stand-aloneType 2 diabetes Other conditions: Fatty LiverView official trial listing → -
Recruiting NCT NCT07053319
SGLT2i, Pioglitazone, and Ketone Production in T2D
Not yet reported The University of Texas Health Science Center at San Antonio 64 participants Est. completion 2027-06-30 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Recruiting NCT NCT07056699
SGLT2i, Pioglitazone, and Ketone Production in T1D
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2027-06-30 1 siteOther conditions: Type1diabetesView official trial listing → -
Recruiting NCT NCT07083388
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Not yet reported Boryung Pharmaceutical Co., Ltd 52 participants Est. completion 2026-07-03 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07083401
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Not yet reported Boryung Pharmaceutical Co., Ltd 40 participants Est. completion 2026-07-05 1 siteOther conditions: Diabete MellitusView official trial listing → -
Recruiting NCT NCT07117630
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Not yet reported Fudan University 60 participants Est. completion 2027-12 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT07462065
Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate
Not yet reported PAEC General Hospital, Islamabad 62 participants Est. completion 2026-06-01 1 siteOther conditions: Infertility Treatment, Pregnancy RatesView official trial listing → -
Completed NCT NCT00013598
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30 participants Est. completion 2004-03 1 siteMASH Other conditions: Fatty LiverView official trial listing → -
Completed NCT NCT00015626
A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
Not yet reported National Center for Research Resources (NCRR) 300 participants 1 siteOther conditions: Insulin Resistance, Diabetes MellitusView official trial listing → -
Completed NCT NCT00062764
Treating Nonalcoholic Steatohepatitis With Pioglitazone
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 18 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: HepatitisView official trial listing → -
Completed NCT NCT00063622
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 247 participants Est. completion 2009-09 8 sitesOther conditions: Liver DiseasesView official trial listing → -
Completed NCT NCT00086502
Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus
Not yet reported Merck Sharp & Dohme LLC 353 participants Est. completion 2005-11Type 2 diabetesView official trial listing → -
Completed NCT NCT00086515
Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 701 participants Est. completion 2007-02-02Other conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT00091949
Insulin Resistance Intervention After Stroke Trial
Not yet reported Yale University 3876 participants Est. completion 2015-11 183 sitesCardiovascular disease Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00094757
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)
Not yet reported Merck Sharp & Dohme LLC 521 participants Est. completion 2006-04-28Type 2 diabetesView official trial listing → -
Completed NCT NCT00097279
Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 230 participants Est. completion 2005-08 73 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00099021
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Not yet reported National Cancer Institute (NCI) 21 participants Est. completion 2008-06-27 1 site Stand-aloneOther conditions: Head and Neck Cancer, Oral LeukoplakiaView official trial listing → -
Completed NCT NCT00101803
Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes
Not yet reported Novartis Pharmaceuticals 527 participants Est. completion 2006-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00106704
Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
Not yet reported Merck Sharp & Dohme LLC 441 participants Est. completion 2007-01Type 2 diabetesView official trial listing → -
Completed NCT NCT00106808
Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
Not yet reported Bristol-Myers Squibb 1440 participants Est. completion 2006-08 195 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00108615
Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance
Not yet reported US Department of Veterans Affairs 48 participants Est. completion 2007-12 1 siteOther conditions: Glucose Metabolism Disorders, DiabetesView official trial listing → -
Completed NCT NCT00133718
A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
Not yet reported Asker & Baerum Hospital 120 participants Est. completion 2012-05-29 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00138554
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
Not yet reported Novartis 318 participants Est. completion 2006-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00143520
Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes
Not yet reported, Not yet reported Daiichi Sankyo 441 participants Est. completion 2005-12 74 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00145340
Pioglitazone Treatment in Polycystic Ovary Syndrome
Not yet reported Odense University Hospital 30 participants Est. completion 2007-01 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00148850
Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 130 participants Est. completion 2004-10 1 siteOther conditions: HIV-Associated Lipodystrophy Syndrome, HIV InfectionsView official trial listing → -
Completed NCT NCT00151710
Effects of Pioglitazone in Congenital Adrenal Hyperplasia
Not yet reported Radboud University Medical Center 1 siteOther conditions: Congenital Adrenal HyperplasiaView official trial listing → -
Completed NCT NCT00153166
ARREST PAD (Peripheral Arterial Disease)
Not yet reported, Not yet reported Brigham and Women's Hospital 76 participants Est. completion 2011-12 1 siteAlcohol use disorder Other conditions: Arterial Occlusive Disease, Insulin ResistanceView official trial listing → -
Completed NCT NCT00154037
Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
Not yet reported Technische Universität Dresden 40 participants Est. completion 2006-09 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Status unknown NCT NCT00155350
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
Not yet reported National Taiwan University Hospital 120 participants Est. completion 2007-12 1 siteOther conditions: Coronary Atherosclerosis, Inflammation, Coronary Heart DiseaseView official trial listing → -
Terminated NCT NCT00159211
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
Not yet reported Assistance Publique - Hôpitaux de Paris 28 participants Est. completion 2007-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00174993
Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
Not yet reported Takeda 4373 participants Est. completion 2005-01 19 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00189163
Pioglitazone in Hepatitis C
Not yet reported University of Michigan 40 participants 1 siteOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00189774
Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
Not yet reported, Not yet reported Astellas Pharma Inc 7 sitesType 2 diabetes Other conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT00196989
Study In People With Type 2 Diabetes
Not yet reported GlaxoSmithKline 448 participants Est. completion 2007-04 143 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00203996
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
Not yet reported University of Chicago 37 participants Est. completion 2008-06 1 site Stand-aloneObstructive sleep apnea Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00212004
Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)
Not yet reported National Cerebral and Cardiovascular Center, Japan 630 participants Est. completion 2018-04 1 siteCardiovascular disease Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00212290
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 140 participants Est. completion 2006-12 2 sitesType 2 diabetes Other conditions: Insulin ResistanceView official trial listing → -
Terminated NCT NCT00214565
GALLANT 6 Tesaglitazar vs. Pioglitazone
Not yet reported AstraZeneca 1450 participants Est. completion 2006-10 74 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00219440
A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS
Not yet reported Pennington Biomedical Research Center 60 participants Est. completion 2006-12 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00220961
Actos Now for Prevention of Diabetes (ACT NOW)
Not yet reported The University of Texas Health Science Center at San Antonio 602 participants Est. completion 2010-04 8 sitesPrediabetesType 2 diabetesView official trial listing → -
Completed NCT NCT00225264
Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.
Not yet reported Takeda 458 participants Est. completion 2006-05 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00225277
Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 547 participants Est. completion 2007-10 79 sitesOther conditions: Diabetes MellitusView official trial listing → -
Terminated NCT NCT00226330
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 1100 participants Est. completion 2006-12 171 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00227110
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Not yet reported The University of Texas Health Science Center at San Antonio 55 participants Est. completion 2006-01 1 siteMASHView official trial listing → -
Terminated NCT NCT00229684
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)
Not yet reported AstraZeneca 100 participants Est. completion 2006-06 21 sitesType 2 diabetesView official trial listing → -
Withdrawn NCT NCT00232362
Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
Not yet reported Texas Tech University Health Sciences Center Est. completion 2008-06Type 2 diabetesView official trial listing → -
Completed NCT NCT00232583
Preservation of Beta-cell Function in Type 2 Diabetes Mellitus
Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2011-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00237237
Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
Not yet reported Novartis 588 participants 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00240370
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
Not yet reported Bristol-Myers Squibb 1159 participants 85 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00242177
Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
Not yet reported University of Illinois at Chicago 30 participants Est. completion 2005-10 1 siteOther conditions: Multiple Sclerosis, Relapsing-RemittingView official trial listing → -
Completed NCT NCT00269061
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
Not yet reported GlaxoSmithKline 32 participants 1 siteOther conditions: Non-Insulin-Dependent Diabetes MellitusView official trial listing → -
Completed NCT NCT00280865
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 500 participants Est. completion 2003-06 110 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00285844
Integrating the Genetic and Metabolic Faces of Obesity
Not yet reported Stanford University 88 participants Est. completion 2012-10 1 siteMetabolic syndrome Other conditions: Insulin Resistance, ObesityView official trial listing → -
Completed NCT NCT00286494
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 493 participants Est. completion 2007-08 77 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00290940
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
Not yet reported Daiichi Sankyo 400 participants Est. completion 2007-04 66 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00295633
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
Not yet reported AstraZeneca 565 participants Est. completion 2008-10 133 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00297063
BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Not yet reported GlaxoSmithKline 350 participants Est. completion 2007-05-31 14 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00300365
Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
Not yet reported University of Pennsylvania 38 participants Est. completion 2010-08 1 siteMetabolic syndromeView official trial listing → -
Withdrawn NCT NCT00306826
Pioglitazone in Impaired Glucose Tolerance
Not yet reported University of Leipzig 120 participants Est. completion 2009-05 7 sitesOther conditions: Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT00308373
Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus
Not yet reported Mayo Clinic 73 participants Est. completion 2005-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00314561
The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
Not yet reported Korea University Anam Hospital 40 participants Est. completion 2006-12 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT00315146
Optimizing Body Composition for Function in Older Adults
Not yet reported Wake Forest University Health Sciences 88 participants Est. completion 2007-04 1 siteOther conditions: Obesity, Overweight With Indications for Weight LossView official trial listing → -
Completed NCT NCT00322868
Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease
Not yet reported University Hospitals Cleveland Medical Center 21 participants Est. completion 2007-04 1 site Stand-aloneOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00327015
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Not yet reported AstraZeneca 1306 participants Est. completion 2008-12 211 sitesOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00328393
Effect of Pioglitazone on Ambulatory Blood Pressure
Not yet reported University of Erlangen-Nürnberg Medical School 2 participants Est. completion 2011-01 1 siteType 2 diabetes Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00328627
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
Not yet reported Takeda 1554 participants Est. completion 2008-03 90 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00331487
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
Not yet reported Takeda 719 participants Est. completion 2004-03 67 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00352287
Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults
Not yet reported Stanford University 60 participants Est. completion 2005-04 1 siteMetabolic syndromePrediabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT00353587
Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
Not yet reported, Not yet reported Gilead Sciences 396 participants Est. completion 2007-11 67 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00362440
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
Not yet reported Beth Israel Deaconess Medical Center 9 participants Est. completion 2011-06 1 siteOther conditions: HIV LipodystrophyView official trial listing → -
Completed NCT NCT00364988
Pioglitazone and Losartan Provides Additional Renoprotection
Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2006-01Type 2 diabetesChronic kidney diseaseView official trial listing → -
Terminated NCT NCT00368017
Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
Not yet reported Vanderbilt University 12 participants Est. completion 2007-09 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT00372060
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 134 participants Est. completion 2008-02-05Type 2 diabetesView official trial listing → -
Terminated NCT NCT00376181
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 96 participants Est. completion 2007-05 73 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT00376870
PIoglitazone for PrEvention of Restenosis in Diabetic Patients
Not yet reported University of Rome Tor Vergata 160 participants Est. completion 2011-04 2 sitesOther conditions: Coronary Atherosclerosis, Coronary Restenosis, DiabetesView official trial listing → -
Completed NCT NCT00377975
"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat
Not yet reported Pennington Biomedical Research Center 96 participants Est. completion 2004-11 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00384215
Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
Not yet reported Sanofi 352 participants Est. completion 2005-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00388518
A Study of Aleglitazar in Patients With Type 2 Diabetes
Not yet reported Hoffmann-La Roche 332 participants Est. completion 2008-03 55 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00395512
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 655 participants Est. completion 2008-02 161 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00395941
Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 40 participants Est. completion 2008-12 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00396227
Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
Not yet reported Novartis Pharmaceuticals 2665 participants 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT00399204
Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh Est. completion 2012-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00402012
"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM
Not yet reported Pennington Biomedical Research Center 24 participants Est. completion 2007-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00402909
Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2007-08 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT00408850
Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity
Not yet reported Baker Heart Research Institute 44 participants Est. completion 2013-02 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT00419484
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
Dokkyo Medical University 1000 participants Est. completion 2008-07 1 siteType 2 diabetesChronic kidney disease Other conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00426413
Ketosis Prone Diabetes in African-Americans
Emory University 44 participants Est. completion 2010-08 1 siteOther conditions: Ketosis Prone Diabetes, Diabetic Ketoacidosis, Severe HyperglycemiaView official trial listing → -
Completed NCT NCT00427999
Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer
Not yet reported Novartis Pharmaceuticals 67 participants Est. completion 2015-08 10 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00432276
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 803 participants Est. completion 2009-06 86 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00433069
Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
Not yet reported University Hospital, Geneva 5 participants Est. completion 2008-01 1 siteOther conditions: Chronic Hepatitis CView official trial listing → -
Withdrawn NCT NCT00437970
Medication in Early Diabetes (MED) Study
Not yet reported Menzies School of Health Research Est. completion 2009-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00441272
Pioglitazone to Treat Fatty Liver in People With HIV Infection
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants 1 siteOther conditions: HIV Infections, Hepatic Steatosis, Insulin ResistanceView official trial listing → -
Completed NCT NCT00443755
Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
Not yet reported Mayo Clinic 28 participants Est. completion 2010-08 1 siteType 2 diabetesMetabolic syndrome Other conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT00449553
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.
Takeda 326 participants Est. completion 2003-09 4 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00459940
The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
Not yet reported University of Aarhus 20 participants Est. completion 2006-03 1 siteOther conditions: Growth Hormone DeficiencyView official trial listing → -
Completed NCT NCT00461006
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
Not yet reported Hoffmann-La Roche 176 participants Est. completion 2008-09 52 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00461058
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.
Not yet reported Hoffmann-La Roche 14 participants Est. completion 2007-12 45 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00467285
Effect of Diabetic Medications on Bone Metabolism
VA Office of Research and Development 96 participants Est. completion 2009-09Type 2 diabetes Other conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00470262
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
Not yet reported VA Office of Research and Development 27 participants Est. completion 2014-06 1 siteMetabolic syndrome Other conditions: Prediabetic StateView official trial listing → -
Completed NCT NCT00479986
Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
Not yet reported IKFE Institute for Clinical Research and Development 92 participants Est. completion 2006-11 2 sitesType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00481663
A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)
Not yet reported Merck Sharp & Dohme LLC 555 participants Est. completion 2006-05-14Other conditions: Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT00482183
Comparison Between Pioglitazone and SES With type2 DM
Not yet reported, Not yet reported Showa University 38 participants Est. completion 2007-06Cardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT00484198
Study of Rivoglitazone in Type 2 Diabetes Mellitus
Not yet reported Daiichi Sankyo 1912 participants Est. completion 2009-02-12 183 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00494312
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
Not yet reported Takeda 2120 participants Est. completion 2005-06Other conditions: Diabetes Mellitus, LiverView official trial listing → -
Completed NCT NCT00494559
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers
Not yet reported Korea University Anam Hospital 240 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Diabetes Mellitus, Coronary Artery StenosisView official trial listing → -
Completed NCT NCT00500331
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)
Not yet reported GlaxoSmithKline 334 participants Est. completion 2008-02-14 136 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00507494
Influence of Pioglitazone for Renal Transplant Function in Diabetics
Not yet reported Technische Universität Dresden Est. completion 2009-09 1 siteOther conditions: Diabetes Mellitus, Kidney Transplantation, ProteinuriaView official trial listing → -
Completed NCT NCT00511108
Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
Not yet reported Merck Sharp & Dohme LLC 211 participants Est. completion 2009-02-24Type 2 diabetesView official trial listing → -
Completed NCT NCT00515632
Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
Not yet reported Rheoscience A/S 409 participants Est. completion 2009-10 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00521742
Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
Not yet reported Takeda 300 participants Est. completion 2003-01Other conditions: Diabetes MellitusView official trial listing → -
Terminated NCT NCT00521820
Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure
Not yet reported Takeda 518 participants Est. completion 2003-10Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00531882
Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
Not yet reported University Hospitals Cleveland Medical Center 25 participants Est. completion 2009-02 2 sitesOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT00532935
MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
Not yet reported Merck Sharp & Dohme LLC 517 participants Est. completion 2009-10-23Type 2 diabetesView official trial listing → -
Completed NCT NCT00541450
A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 492 participants Est. completion 2010-01-16Type 2 diabetesView official trial listing → -
Terminated NCT NCT00543959
Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
Not yet reported Merck Sharp & Dohme LLC 346 participants Est. completion 2007-08Type 2 diabetesView official trial listing → -
Completed NCT NCT00545233
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Not yet reported Hoffmann-La Roche 155 participants Est. completion 2010-12 66 sitesOther conditions: Hepatitis C, ChronicView official trial listing → -
Completed NCT NCT00545857
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Not yet reported Stony Brook University 15 participants Est. completion 2012-05 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00570622
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
Not yet reported Medical University of Vienna 20 participants Est. completion 2008-11 1 siteOther conditions: Cirrhosis, Ascites, Portal HypertensionView official trial listing → -
Completed NCT NCT00571506
Effect of Thiazolidinedione Treatment Vascular Risk Markers
Not yet reported University of Arkansas 25 participants Est. completion 2007-08 1 siteType 2 diabetes Other conditions: Vascular DiseasesView official trial listing → -
Terminated NCT NCT00571519
Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus
Not yet reported Daiichi Sankyo 94 participants Est. completion 2008-05-23 18 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00575874
Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes
Not yet reported Daiichi Sankyo Co., Ltd. 150 participants Est. completion 2009-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00576784
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin
Not yet reported IKFE Institute for Clinical Research and Development 100 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT00579813
Mechanisms Underlying Metabolic Syndrome in Obesity
Not yet reported Philip Kern 70 participants Est. completion 2011-01 2 sitesMetabolic syndromePrediabetes Other conditions: Insulin ResistanceView official trial listing → -
Terminated NCT NCT00586261
Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
Not yet reported Mayo Clinic 36 participants Est. completion 2009-07 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT00598013
Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
Not yet reported Yonsei University 83 participants Est. completion 2007-11 1 siteOther conditions: Kidney Transplantation, Insulin Resistance, AtherosclerosisView official trial listing → -
Completed NCT NCT00598793
Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy
Not yet reported Novo Nordisk A/S 242 participants Est. completion 2004-03 27 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00609856
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
Not yet reported Skane University Hospital 36 participants Est. completion 2006-12 1 siteType 2 diabetes Other conditions: Secondary Drug FailureView official trial listing → -
Completed NCT NCT00631007
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
Not yet reported InteKrin Therapeutics, Inc. 367 participants Est. completion 2009-09 66 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00633282
Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease
Not yet reported Xin Gao 184 participants Est. completion 2011-08 3 sitesMASLDView official trial listing → -
Completed NCT NCT00634036
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
Not yet reported Fernando Holguin 23 participants Est. completion 2012-04 2 sitesOther conditions: AsthmaView official trial listing → -
Completed NCT NCT00637273
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Not yet reported AstraZeneca 514 participants Est. completion 2009-07 62 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00641043
Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone
Not yet reported Boehringer Ingelheim 389 participants 43 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00649012
Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg
Not yet reported Mylan Pharmaceuticals Inc 40 participants Est. completion 2003-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00649558
Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg
Not yet reported Mylan Pharmaceuticals Inc 36 participants Est. completion 2003-03 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00655863
Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.
Not yet reported Takeda 71 participants Est. completion 2009-12 2 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00656851
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24 participants Est. completion 2010-08 1 siteCardiovascular diseaseMetabolic syndrome Other conditions: HIV Infections, Insulin Resistance, HIV LipodystrophyView official trial listing → -
Completed NCT NCT00656864
Pioglitazone Incretin Study
Not yet reported University of Vermont 24 participants Est. completion 2010-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00671515
Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
Not yet reported Joseph Calabrese, MD 23 participants Est. completion 2011-11 1 siteMetabolic syndrome Other conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT00672919
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
Not yet reported Takeda 305 participants Est. completion 2004-08 53 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00676260
Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin
Not yet reported Takeda 29 participants Est. completion 2004-08 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00676338
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Not yet reported AstraZeneca 820 participants Est. completion 2011-01 106 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00680745
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
Not yet reported AstraZeneca 597 participants Est. completion 2010-05 66 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT00681733
Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)
Not yet reported Govind Ballabh Pant Hospital 20 participants Est. completion 2008-12 1 siteOther conditions: Metabolic Parameters and Liver HistologyView official trial listing → -
Completed NCT NCT00683878
Add-on to Thiazolidinedione (TZD) Failures
Not yet reported AstraZeneca 972 participants Est. completion 2010-06 89 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00690118
Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
Not yet reported University of Ulm 219 participants Est. completion 2010-06 15 sitesOther conditions: Amyotrophic Lateral SclerosisView official trial listing → -
Completed NCT NCT00694759
Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
Not yet reported Oregon Health and Science University 37 participants Est. completion 2011-07 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00708175
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
Not yet reported Takeda 156 participants Est. completion 2011-02 34 sitesOther conditions: Bone MetabolismView official trial listing → -
Completed NCT NCT00722631
Anti-Inflammatory Effects of Pioglitazone
Not yet reported Kurume University 70 participants Est. completion 2012-04 1 sitePrediabetesType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Terminated NCT NCT00722917
Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 323 participants Est. completion 2009-04 8 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00727857
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
Not yet reported Takeda 600 participants Est. completion 2008-08 77 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00736099
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
Not yet reported Boehringer Ingelheim 2122 participants 232 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00736996
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
Not yet reported University of Colorado, Denver 78 participants Est. completion 2013-12 1 siteOther conditions: Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT00737347
Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
Not yet reported Northwestern University 39 participants Est. completion 2008-04 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Terminated NCT NCT00742326
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2013-01 2 sitesOther conditions: HIV, Hepatitis C, Liver Disease, Fatty Liver, SteatosisView official trial listing → -
Terminated NCT NCT00743327
Androgen Deprivation Therapy Study
National Institute on Aging (NIA) 1 participants Est. completion 2012-08 1 siteMetabolic syndrome Other conditions: Hypogonadism, Diabetes, InflammationView official trial listing → -
Completed NCT NCT00745225
Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients
Not yet reported The University of Hong Kong 160 participants Est. completion 2014-12 1 siteOther conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT00745914
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
Not yet reported The University of Hong Kong 22 participants Est. completion 2013-12 2 sitesOther conditions: Endstage Renal Disease, DiabetesView official trial listing → -
Status unknown NCT NCT00749047
How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?
Not yet reported Christchurch Hospital 12 participants Est. completion 2010-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00754403
Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
Not yet reported Takeda 312 participants Est. completion 2006-10Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00760578
A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
Not yet reported Metabolic Solutions Development Company 86 participants Est. completion 2009-02 8 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00762736
Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 704 participants Est. completion 2005-10 78 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00763139
Inflammation and Insulin Resistance in Rheumatoid Arthritis
Not yet reported Vanderbilt University 34 participants Est. completion 2013-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00763815
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
Not yet reported Sanofi 484 participants Est. completion 2011-06 150 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00765817
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 261 participants Est. completion 2010-01 59 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00770445
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
Not yet reported Takeda 121 participants Est. completion 2010-07 18 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00770497
Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.
Not yet reported Takeda 172 participants Est. completion 2008-05 13 sitesOther conditions: Inflammation, HypertensionView official trial listing → -
Completed NCT NCT00770575
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
Not yet reported Takeda 148 participants Est. completion 2006-10Cardiovascular diseaseView official trial listing → -
Completed NCT NCT00770640
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
Not yet reported Takeda 40 participants Est. completion 2010-06 9 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00770835
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
Not yet reported Takeda 39 participants Est. completion 2011-05 2 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00770952
Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
Not yet reported Takeda 91 participants Est. completion 2008-12 17 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00771004
Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.
Not yet reported Takeda 63 participants Est. completion 2009-02 7 sitesCardiovascular diseaseType 2 diabetes Other conditions: Oxidative StressView official trial listing → -
Withdrawn NCT NCT00775164
Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
Not yet reported University of Minnesota Est. completion 2011-02Other conditions: Obesity, Insulin ResistanceView official trial listing → -
Completed NCT NCT00780234
Pioglitazone for Lung Cancer Chemoprevention
Not yet reported VA Office of Research and Development 92 participants Est. completion 2017-08 2 sites Stand-aloneOther conditions: Lung Cancer, Endobronchial DysplasiaView official trial listing → -
Completed NCT NCT00780715
Response To Oral Agents in Diabetes (ROAD)- Pilot Study
Not yet reported University of Dundee 29 participants Est. completion 2009-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00782795
Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality
Not yet reported University of Michigan 64 participants Est. completion 2013-12 1 siteOther conditions: Chronic Pancreatitis, Insulin Resistance, Normal or Mildly Abnormal Stool Fat LevelsView official trial listing → -
Completed NCT NCT00789750
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Not yet reported Daiichi Sankyo 562 participants Est. completion 2012-07 141 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00806520
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
HealthPartners Institute 16 participants Est. completion 2011-08 5 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00811681
Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Not yet reported Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2013-03 1 siteOther conditions: Friedreich's AtaxiaView official trial listing → -
Terminated NCT NCT00814372
Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin
Not yet reported Gilead Sciences 242 participants Est. completion 2010-02 26 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00815399
Pioglitazone Versus Metformin in Type 2 Diabetes
Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00816218
Molecular Mechanisms of Type 2 Diabetes Mellitus
Not yet reported The University of Texas Health Science Center at San Antonio 39 participants Est. completion 2008-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00819325
Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
Not yet reported Queen Elizabeth II Health Sciences Centre 50 participants Est. completion 2007-03 1 siteCardiovascular diseaseType 2 diabetes Other conditions: Angina Pectoris, Percutaneous Coronary InterventionView official trial listing → -
Terminated NCT NCT00825266
Insulin Resistance in Pulmonary Arterial Hypertension
Not yet reported Stanford University 2 participants Est. completion 2010-05 1 siteOther conditions: Hypertension, PulmonaryView official trial listing → -
Completed NCT NCT00827892
Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage
Not yet reported The University of Texas Health Science Center, Houston 84 participants Est. completion 2013-11 1 siteOther conditions: Intracerebral HemorrhageView official trial listing → -
Completed NCT NCT00835120
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
Not yet reported University Hospitals Cleveland Medical Center 34 participants Est. completion 2013-04 1 siteMetabolic syndrome Other conditions: Bipolar Depression, Insulin ResistanceView official trial listing → -
Completed NCT NCT00839527
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
Not yet reported GlaxoSmithKline 685 participants Est. completion 2013-04 358 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00843791
Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin
Not yet reported Oregon Health and Science University 6 participants Est. completion 2011-05 1 siteOther conditions: Obesity, Insulin ResistanceView official trial listing → -
Status unknown NCT NCT00846716
Shiga Progression of Diabetes, Nephropathy and Retinopathy
Not yet reported Shiga University 400 participants Est. completion 2011-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00849056
Safety and Efficacy of Albiglutide in Type 2 Diabetes
Not yet reported GlaxoSmithKline 310 participants Est. completion 2013-01 331 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00855010
Pioglitazone on Pancreatic Steatosis and Bone Health
Not yet reported University of Texas Southwestern Medical Center 42 participants Est. completion 2013-12 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT00861341
Effects of Pioglitazone on Platelet Function
Not yet reported University of Rochester 40 participants Est. completion 2011-06 1 siteOther conditions: Diabetes, Platelet Function, HealthyView official trial listing → -
Terminated NCT NCT00867126
Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
Not yet reported University of Texas Southwestern Medical Center 6 participants Est. completion 2012-02 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00868140
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Not yet reported Virginia Commonwealth University 51 participants Est. completion 2011-08 2 sitesOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00879970
Thiazolidinedione Intervention With Vitamin D Evaluation
Not yet reported GlaxoSmithKline 1332 participants Est. completion 2010-11 331 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00885352
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
Not yet reported Merck Sharp & Dohme LLC 313 participants Est. completion 2010-11-10Type 2 diabetesView official trial listing → -
Completed NCT NCT00892372
Relationship Between Body Weight and Glycohemoglobin
Saitama Medical University 100 participants Est. completion 2009-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00904046
Pathophysiology of Uric Acid Nephrolithiasis
Not yet reported University of Texas Southwestern Medical Center 172 participants Est. completion 2017-11-16 1 site Stand-aloneOther conditions: Uric Acid Kidney Stone DiseaseView official trial listing → -
Completed NCT NCT00919555
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Not yet reported, Not yet reported Phoenix Neurological Associates, LTD 28 participants Est. completion 2012-03 1 siteOther conditions: Amyotrophic Lateral SclerosisView official trial listing → -
Terminated NCT NCT00923949
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 1 participants Est. completion 2010-03 2 sitesOther conditions: Non-Small-Cell Lung CancerView official trial listing → -
Completed NCT NCT00926016
Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects
Not yet reported Brooke Army Medical Center 23 participants Est. completion 2010-09 1 siteOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT00926341
The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
Not yet reported Aligarh Muslim University 110 participants Est. completion 2008-09 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT00926614
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
Not yet reported Brooke Army Medical Center 20 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Hepatitis cView official trial listing → -
Terminated NCT NCT00927290
Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance
Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 40 participants Est. completion 2012-07-06 1 siteOther conditions: Chronic Hepatitis C, Insulin ResistanceView official trial listing → -
Completed NCT NCT00927355
Effect of Thiazolidinediones on Human Bone
Not yet reported Emory University 10 participants Est. completion 2011-07 1 siteOther conditions: Osteoblast, Adipocytes, Bone Density, Osteocalcin, Adiponectin, Mesenchymal Stem CellsView official trial listing → -
Terminated NCT NCT00951379
Pioglitazone for Oral Premalignant Lesions
Not yet reported National Cancer Institute (NCI) 52 participants Est. completion 2014-03 13 sites Stand-aloneOther conditions: Oral LeukoplakiaView official trial listing → -
Completed NCT NCT00953498
Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins
Not yet reported Centre Hospitalier Universitaire Dijon 40 participants Est. completion 2012-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00964106
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sitesOther conditions: Drug InteractionsView official trial listing → -
Terminated NCT NCT00970424
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
Not yet reported Forest Laboratories 252 participants 118 sitesOther conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT00972283
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 1006 participants Est. completion 2010-10-28 136 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00975286
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Not yet reported Sanofi 446 participants Est. completion 2011-08 140 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00982202
Pioglitazone in Alzheimer Disease
Not yet reported National Institute on Aging (NIA) 25 participants Est. completion 2005-01 2 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT00991055
Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes
Not yet reported National Cheng-Kung University Hospital 40 participants Est. completion 2010-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00994682
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
Not yet reported University of Florida 176 participants Est. completion 2014-12 1 siteMASHMASLDType 2 diabetesView official trial listing → -
Completed NCT NCT00996658
Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
Not yet reported Boehringer Ingelheim 278 participants 52 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01001013
Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects
Not yet reported LG Life Sciences 24 participants Est. completion 2009-12 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01006018
DPP-4 Inhibition and TZD for DM Prevention
Not yet reported Emory University 3 participants Est. completion 2011-12 2 sitesOther conditions: Prediabetic StateView official trial listing → -
Completed NCT NCT01009580
Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 447 participants Est. completion 2010-08-23 53 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Status unknown NCT NCT01010243
Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
Not yet reported, Not yet reported University of Regensburg 54 participants Est. completion 2016-10 6 sitesOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT01023620
HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Not yet reported University of Texas Southwestern Medical Center 4 participants Est. completion 2010-05-31 1 siteOther conditions: HIV InfectionsView official trial listing → -
Status unknown NCT NCT01025765
The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
Not yet reported National Taiwan University Hospital 80 participants Est. completion 2012-12 1 siteOther conditions: Chronic Hepatitis CView official trial listing → -
Completed NCT NCT01028391
30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
Not yet reported Merck Sharp & Dohme LLC 317 participants Est. completion 2009-01-01Type 2 diabetesView official trial listing → -
Completed NCT NCT01028963
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
Not yet reported Amgen 159 participants Est. completion 2010-11 28 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01040819
Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?
Not yet reported Baylor College of Medicine 25 participants Est. completion 2011-12 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01043029
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
Not yet reported Hoffmann-La Roche 302 participants Est. completion 2012-07 80 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01055223
Fracture Risk With Thiazolidinediones
GlaxoSmithKline 98483 participants Est. completion 2010-03Other conditions: Fractures, Bone, Type II DiabetesView official trial listing → -
Completed NCT NCT01065298
Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2
Post Graduate Institute of Medical Education and Research, Chandigarh 30 participants Est. completion 2011-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01068444
The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis
Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 90 participants Est. completion 2020-07 2 sitesOther conditions: HepatitisView official trial listing → -
Completed NCT NCT01076075
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
Not yet reported Merck Sharp & Dohme LLC 427 participants Est. completion 2012-01-19Type 2 diabetesView official trial listing → -
Completed NCT NCT01082120
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 28 participants Est. completion 2010-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01087567
INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
Not yet reported Ohio University 23 participants Est. completion 2014-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01088594
A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers
Not yet reported Solvay Pharmaceuticals 12 participants Est. completion 2010-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01088919
A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Pioglitazone Hydrochloride When Given Together to Healthy Subjects
Not yet reported Astellas Pharma Inc 64 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Healthy, Pharmacokinetics of ASP1941View official trial listing → -
Terminated NCT NCT01089790
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Not yet reported Forest Laboratories 141 participants 149 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01090752
Renal and Hormonal Effects of Pioglitazone
Not yet reported University Hospital, Geneva 16 participants Est. completion 2007-10 1 siteOther conditions: Diabetes, HypertensionView official trial listing → -
Completed NCT NCT01095666
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Not yet reported AstraZeneca 1484 participants Est. completion 2013-03 33 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01103414
Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients
Not yet reported Metabolic Solutions Development Company 356 participants Est. completion 2011-12 24 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01106690
The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
Not yet reported Janssen Research & Development, LLC 344 participants Est. completion 2012-07 83 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01107717
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
Not yet reported The University of Texas Health Science Center at San Antonio 318 participants Est. completion 2023-02-03 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01109030
Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
Not yet reported, Not yet reported Tehran University of Medical Sciences 50 participants Est. completion 2011-10 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01115712
Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)
Not yet reported Merck Sharp & Dohme LLC 35 participants Est. completion 2010-09Other conditions: Healthy, Overweight, ObesityView official trial listing → -
Terminated NCT NCT01124656
Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
Not yet reported Takeda 26 participants Est. completion 2007-05Type 2 diabetesView official trial listing → -
Completed NCT NCT01133561
Pioglitazone in Psoriasis- A Clinical and Molecular Study.
Not yet reported Cairo University 48 participants Est. completion 2010-08 1 siteOther conditions: PsoriasisView official trial listing → -
Terminated NCT NCT01134835
PPAR-gamma: a Novel Therapeutic Target for Asthma?
Not yet reported University of Nottingham 68 participants Est. completion 2012-07 1 siteOther conditions: AsthmaView official trial listing → -
Completed NCT NCT01135394
Pharmacogenomics of Thiazolidinediones
Not yet reported University of Maryland, Baltimore 114 participants Est. completion 2018-05-31 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01147627
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Not yet reported Sun Yat-sen University 416 participants Est. completion 2012-12 25 sitesType 2 diabetes Other conditions: Newly DiagnosedView official trial listing → -
Completed NCT NCT01151670
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Not yet reported Wake Forest University Health Sciences 18 participants Est. completion 2014-08 1 siteOther conditions: Brain Neoplasms, Malignant, Brain Neoplasms, Benign, Malignant Meningioma, Glioblastoma Multiforme, Anaplastic AstrocytomaView official trial listing → -
Completed NCT NCT01156597
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
Not yet reported University of Miami 30 participants Est. completion 2010-09 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01157975
Study the Relationship Between Obesity and Hepatitis C Replication
Not yet reported University of California, San Diego Est. completion 2014-09 2 sitesOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT01161394
Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
Not yet reported University at Buffalo 24 participants Est. completion 2003-10 1 siteOther conditions: InflammationView official trial listing → -
Completed NCT NCT01165190
Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans
Arizona State University 20 participants Est. completion 2010-05 2 sitesOther conditions: Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT01174056
Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging
Not yet reported Washington University School of Medicine 39 participants Est. completion 2014-03 1 siteOther conditions: Lung InflammationView official trial listing → -
Status unknown NCT NCT01175486
Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
Not yet reported Taipei Veterans General Hospital, Taiwan 200 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01175824
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
Not yet reported Eli Lilly and Company 478 participants Est. completion 2012-11 18 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01183013
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks
Not yet reported Boehringer Ingelheim 936 participants Est. completion 2013-02 132 sitesType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01184144
Endometriosis: Immunomodulation
Not yet reported, Not yet reported University of Wisconsin, Madison Est. completion 2012-05Other conditions: EndometriosisView official trial listing → -
Completed NCT NCT01186250
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Not yet reported Stanford University 18 participants Est. completion 2013-12 1 siteOther conditions: Cardiac Allograft VasculopathyView official trial listing → -
Completed NCT NCT01205282
Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)
Not yet reported Evdokia Anagnostou 28 participants Est. completion 2015-09 1 siteOther conditions: Autism Spectrum DisordersView official trial listing → -
Status unknown NCT NCT01206400
Effect of Pioglitazone on Testosterone in Eugonadal Men With Type 2 Diabetes Mellitus - A Pilot Study
Post Graduate Institute of Medical Education and Research, Chandigarh 45 participants Est. completion 2012-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01210001
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
Not yet reported Boehringer Ingelheim 499 participants 68 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01217073
A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)
Not yet reported Merck Sharp & Dohme LLC 685 participants Est. completion 2013-04-01Type 2 diabetesView official trial listing → -
Completed NCT NCT01223196
Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
Not yet reported The University of Texas Health Science Center at San Antonio 60 participants Est. completion 2011-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01225081
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients
Not yet reported Astellas Pharma Inc 152 participants Est. completion 2012-04-28 7 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01230749
A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 89 participants Est. completion 2011-06Type 2 diabetesView official trial listing → -
Completed NCT NCT01258322
Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients
Not yet reported Huashan Hospital 70 participants Est. completion 2008-09 Stand-aloneOther conditions: Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, InflammationView official trial listing → -
Completed NCT NCT01276327
Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Not yet reported Boehringer Ingelheim 64 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01280123
Pioglitazone in Early Parkinson's Disease
Not yet reported University of Rochester 210 participants Est. completion 2014-05 38 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01289119
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
Not yet reported Takeda 506 participants Est. completion 2011-12 21 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT01289639
Insulin Resistance in Non-alcoholic Fatty Liver Disease
Not yet reported VA Office of Research and Development 11 participants Est. completion 2014-08 1 siteOther conditions: Fatty LiverView official trial listing → -
Completed NCT NCT01301027
Effect of Adipokines in Hemodialysis Patients
Not yet reported University of Utah 95 participants Est. completion 2015-12 2 sitesOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT01309854
Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy Subjects
Not yet reported AstraZeneca 15 participants Est. completion 2011-05 1 siteOther conditions: Rheumatoid Arthritis, Healthy Volunteers, Pharmacokinetics, Pioglitazone, Drug-drug Interaction, Amount of Pioglitazone in BloodView official trial listing → -
Completed NCT NCT01318070
Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Not yet reported, Not yet reported Takeda 339 participants Est. completion 2008-10Type 2 diabetesView official trial listing → -
Completed NCT NCT01318122
Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Not yet reported, Not yet reported Takeda 336 participants Est. completion 2009-08Type 2 diabetesView official trial listing → -
Completed NCT NCT01322308
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
Not yet reported National Heart Institute, Mexico 30 participants Est. completion 2012-01Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01331967
The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)
Not yet reported Korea University Anam Hospital 94 participants Est. completion 2013-08 1 siteOther conditions: Diabetic Stable Angina, Diabetic Unstable AnginaView official trial listing → -
Status unknown NCT NCT01339143
Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes
Not yet reported Korea University Anam Hospital 80 participants Est. completion 2013-05 1 siteOther conditions: Diabetes Mellitus, Oxidative StressView official trial listing → -
Terminated NCT NCT01341730
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Not yet reported The Catholic University of Korea 41 participants Est. completion 2012-08 1 siteCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT01342380
Pioglitazone and Quetiapine XR Pharmacogenetic Study
University Hospitals Cleveland Medical Center 42 participants Est. completion 2015-05 1 siteOther conditions: Bipolar Disorder, Major Depressive DisorderView official trial listing → -
Terminated NCT NCT01342770
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2013-02 1 site Stand-aloneOther conditions: Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT01346254
Glucose Control in Pre-Diabetic Renal Transplant Patients
Not yet reported Marcus Saemann 51 participants Est. completion 2011-11 1 site Stand-alonePrediabetes Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01352182
Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 12 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Severe Sepsis, Septic ShockView official trial listing → -
Completed NCT NCT01395784
Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone
Not yet reported New York State Psychiatric Institute 32 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: Opioid AbuseView official trial listing → -
Terminated NCT NCT01395797
Pioglitazone for Heroin and for Nicotine Dependence
Not yet reported, Not yet reported New York State Psychiatric Institute 82 participants Est. completion 2014-06 1 siteOther conditions: Heroin Dependence, Nicotine DependenceView official trial listing → -
Completed NCT NCT01396564
Pioglitazone and Metformin in Diabetic Children
Not yet reported, Not yet reported Coordinación de Investigación en Salud, Mexico 56 participants Est. completion 2011-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01431521
Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)
Not yet reported Merck Sharp & Dohme LLC 31 participants Est. completion 2012-10-01 Stand-aloneOther conditions: Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT01432405
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
Not yet reported Baylor College of Medicine 24 participants Est. completion 2009-06 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01456117
Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants
Not yet reported Takeda 61 participants Est. completion 2012-07 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01471808
Effects of Different Early Intensive Therapies on Long-term β-cell Function
Not yet reported Sun Yat-sen University 264 participants Est. completion 2018-12Type 2 diabetesView official trial listing → -
Completed NCT NCT01489943
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Not yet reported GlaxoSmithKline 24 participants Est. completion 2011-11-10 1 siteOther conditions: Crohn's DiseaseView official trial listing → -
Terminated NCT NCT01517165
Pioglitazone to Treat Opioid Withdrawal Symptoms
Not yet reported National Institute on Drug Abuse (NIDA) 24 participants Est. completion 2015-02-02 1 siteOther conditions: Opioid-Related DisordersView official trial listing → -
Completed NCT NCT01559857
Pioglitazone in Patients With Mood Disorders
Not yet reported Stanford University 37 participants Est. completion 2014-06 1 siteOther conditions: Major Depressive Disorder, Insulin ResistanceView official trial listing → -
Completed NCT NCT01570660
Phielix et al.: Hepatic Fat Content and Adipokines
Not yet reported German Diabetes Center 24 participants Est. completion 2012-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01588470
Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)
Not yet reported The University of Texas Health Science Center at San Antonio 130 participants Est. completion 2011-12Type 2 diabetes Other conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT01589445
Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects
Not yet reported University of Dhaka 77 participants Est. completion 2010-06 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01612858
Metabolic Abnormalities in HIV-infected Persons
Not yet reported Tufts Medical Center 20 participants Est. completion 2014-11 1 siteOther conditions: Lipodystrophy, HIV InfectionView official trial listing → -
Status unknown NCT NCT01614301
Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma
Not yet reported, Not yet reported University of Regensburg 136 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: Advanced MelanomaView official trial listing → -
Terminated NCT NCT01631630
Role of Proinflammatory Signaling in Alcohol Craving
Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 16 participants Est. completion 2015-09 1 siteAlcohol use disorder Other conditions: Stress, Alcohol-Related DisordersView official trial listing → -
Completed NCT NCT01637935
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Takeda 193099 participants Est. completion 2014-08Other conditions: Diabetes, Bladder CancerView official trial listing → -
Completed NCT NCT01655719
Pioglitazone in Thyroid Cancers
Not yet reported University of Michigan 1 participants Est. completion 2017-03-31 4 sitesOther conditions: Thyroid Cancers That Contain the PAX8-PPARgamma Fusion GeneView official trial listing → -
Completed NCT NCT01686711
A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322
Not yet reported Takeda 207 participants Est. completion 2013-12 25 sitesOther conditions: Diabetes MellitusView official trial listing → -
Withdrawn NCT NCT01695707
Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients
Not yet reported University of Rochester Est. completion 2014-06 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT01697592
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
Not yet reported Merck Sharp & Dohme LLC 585 participants Est. completion 2014-05-08Type 2 diabetesView official trial listing → -
Terminated NCT NCT01703260
Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis
Not yet reported AstraZeneca 20 participants Est. completion 2014-09 4 sitesOther conditions: Nonalcoholic SteatohapatitisView official trial listing → -
Terminated NCT NCT01717040
Pioglitazone for the Treatment of Bipolar Depression
Not yet reported University Hospitals Cleveland Medical Center 37 participants Est. completion 2016-03 1 siteOther conditions: Bipolar Disorder, Insulin ResistanceView official trial listing → -
Completed NCT NCT01748994
Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
Not yet reported Pennington Biomedical Research Center 63 participants Est. completion 2016-12 2 sitesMetabolic syndrome Other conditions: ObesityView official trial listing → -
Completed NCT NCT01759823
Bone Marrow Derived Stem Cell Transplantation in T2DM
Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 30 participants Est. completion 2015-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01797666
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fasting Conditions
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01798706
Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Not yet reported Sanofi 350 participants Est. completion 2015-02 83 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01798940
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride Tablets Under Fed Conditions
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01799850
The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle
Not yet reported East Tennessee State University 12 participants Est. completion 2004-03 1 siteOther conditions: Diabetes Type 2View official trial listing → -
Completed NCT NCT01800227
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01800240
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fed Conditions
Not yet reported Torrent Pharmaceuticals Limited 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01817400
Mediators of Abnormal Reproductive Function in Obesity (MARO)
Not yet reported University of Colorado, Denver 10 participants Est. completion 2014-12 1 siteOther conditions: Infertility, Female, ObesityView official trial listing → -
Status unknown NCT NCT01819402
Pioglitazone Decreases Visceral Fat Metabolism
Not yet reported Kurume University 60 participants 1 siteOther conditions: To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingView official trial listing → -
Completed NCT NCT01838317
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
Not yet reported University of Texas Southwestern Medical Center 14 participants Est. completion 2017-09-20 1 siteOther conditions: Cancer of the PancreasView official trial listing → -
Completed NCT NCT01873001
A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants
Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2013-07 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01882907
Safety and Efficacy Study to Compare Vildagliptin to Pioglitazone as Adding on Metformin in Type 2 Diabetes
Not yet reported Pusan National University Hospital 287 participants Est. completion 2013-03 15 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01894568
A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
Not yet reported Eli Lilly and Company 388 participants Est. completion 2015-04 31 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT01895569
Triple Therapy in Type 2 Diabetic Patients
Not yet reported University of Pavia 64 participants Est. completion 2016-06 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01911728
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Not yet reported Astellas Pharma Europe B.V. 14 participants Est. completion 2012-02-21 2 sitesOther conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC)View official trial listing → -
Completed NCT NCT01935804
Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
Not yet reported King Abdulaziz University 440 participants Est. completion 2014-01 1 siteType 2 diabetes Other conditions: Diabetes Mellitus, Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT01947790
Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
Not yet reported Xiang Guang-da 120 participants Est. completion 2015-07 2 sitesOther conditions: LVM, Type 2 Diabetic Patients With IHD, Endothelial FunctionView official trial listing → -
Completed NCT NCT01963663
Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
Not yet reported Tehran University of Medical Sciences 84 participants Est. completion 2013-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01972724
Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
Not yet reported Takeda 114 participants Est. completion 2016-10-17 9 sitesOther conditions: Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT01990300
Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
Takeda 3281 participants Est. completion 2015-03-31 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02002975
Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"
Takeda 18223 participants Est. completion 2013-06-30Type 2 diabetesView official trial listing → -
Completed NCT NCT02003014
Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"
Takeda 899 participants Est. completion 2012-01Type 2 diabetesView official trial listing → -
Completed NCT NCT02024971
Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus
Takeda 1103 participants Est. completion 2013-11Type 2 diabetesView official trial listing → -
Completed NCT NCT02027103
Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients
Not yet reported Tehran University of Medical Sciences 102 participants Est. completion 2012-04 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT02072096
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 192 participants Est. completion 2015-10 34 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02098733
Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
Takeda 1168 participants Est. completion 2014-05Type 2 diabetesView official trial listing → -
Completed NCT NCT02098746
Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
Takeda 294 participants Est. completion 2014-07Type 2 diabetesView official trial listing → -
Completed NCT NCT02099838
Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
Not yet reported Huazhong University of Science and Technology 98 participants Est. completion 2013-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02133118
Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.
Medical Research Foundation, The Netherlands 16293 participants Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02133625
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Not yet reported Dana-Farber Cancer Institute 14 participants Est. completion 2026-01 2 sitesOther conditions: Advanced Solid Tumor, Metastatic Solid TumorView official trial listing → -
Status unknown NCT NCT02142309
Glycemic Durability After Metformin Failure
Not yet reported University of Campania Luigi Vanvitelli 450 participants Est. completion 2017-01 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02172235
Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers
Not yet reported Boehringer Ingelheim 20 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02181842
Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>
Takeda 246 participants Est. completion 2011-06-30Type 2 diabetesView official trial listing → -
Completed NCT NCT02183337
Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 20 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02183636
Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female Subjects
Not yet reported Boehringer Ingelheim 39 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02192684
Obesity, Sleep Apnea, and Insulin Resistance
Not yet reported Stanford University 45 participants Est. completion 2015-03Obstructive sleep apnea Other conditions: Insulin SensitivityView official trial listing → -
Terminated NCT NCT02195791
Neuroprotection of Pioglitazone in Acute Ischemic Stroke
Not yet reported Taipei Medical University Shuang Ho Hospital 4 participants Est. completion 2016-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02222441
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
Not yet reported Pfizer 14 participants Est. completion 2014-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02231021
The Practical Evidence of Antidiabetic Combination Therapy in Korea
Not yet reported Kun-Ho Yoon 216 participants Est. completion 2019-01-28 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02236962
Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
Not yet reported Bayside Health 42 participants 1 siteType 2 diabetesCardiovascular disease Other conditions: ObesityView official trial listing → -
Status unknown NCT NCT02265276
A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease
Not yet reported Command Hospital, India 100 participants Est. completion 2015-09 1 siteOther conditions: Fatty LiverView official trial listing → -
Completed NCT NCT02276365
Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 20 participantsOther conditions: HealthyView official trial listing → -
Completed NCT NCT02278562
Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
Not yet reported VA Office of Research and Development 33 participants Est. completion 2017-03-01 1 siteOther conditions: ESRDView official trial listing → -
Terminated NCT NCT02284906
AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease
Not yet reported Takeda 40 participants Est. completion 2018-05-08 43 sitesOther conditions: Mild Cognitive Impairment Due to Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02292290
Trial for People With Established Type 2 Diabetes During Ramadan
Not yet reported University of Leicester 99 participants Est. completion 2012-12 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02298192
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Not yet reported Novo Nordisk A/S 420 participants Est. completion 2015-12-23 84 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Terminated NCT NCT02303405
Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus
Not yet reported Charles Drew University of Medicine and Science 22 participants Est. completion 2017-11 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02315287
Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
Not yet reported Seoul National University Bundang Hospital 190 participants Est. completion 2021-12-31 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02341703
Ovulation Induction in Clomiphene Citrate Resistant PCO Women
Not yet reported Cairo University 100 participants Est. completion 2015-07 1 siteOther conditions: Polycystic Ovary Syndrome, InfertilityView official trial listing → -
Completed NCT NCT02342067
Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination
Not yet reported Tobira Therapeutics, Inc. 20 participants Est. completion 2015-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02347813
Preventing Squamous Cell Skin Cancer
Not yet reported University of Rochester 12 participants Est. completion 2019-06-01Other conditions: Squamous Cell Carcinoma of the SkinView official trial listing → -
Terminated NCT NCT02365233
Fatty Liver Study in Patients With Type II Diabetes
Not yet reported The University of Texas Medical Branch, Galveston 5 participants Est. completion 2016-12-31 1 siteOther conditions: Type II Diabetes, Nonalcoholic Fatty LiverView official trial listing → -
Status unknown NCT NCT02426294
Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
Not yet reported Pusan National University Hospital 154 participants Est. completion 2016-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT02429232
A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers
Not yet reported National Taiwan University Hospital 160 participants Est. completion 2017-12Other conditions: Osteoporosis, Diabetes MellitusView official trial listing → -
Completed NCT NCT02473627
A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
Not yet reported Daiichi Sankyo 18 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02503865
Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
Not yet reported, Not yet reported Nazarbayev University 351 participants Est. completion 2014-12 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT02535832
Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)
Not yet reported Ohio State University 16 participants Est. completion 2022-10 1 siteOther conditions: Rheumatoid Arthritis, Insulin ResistanceView official trial listing → -
Withdrawn NCT NCT02585765
Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI
Not yet reported James J. Peters Veterans Affairs Medical Center Est. completion 2018-04-01 1 siteOther conditions: Spinal Cord Injury, Pressure UlcersView official trial listing → -
Active, not recruiting NCT NCT02592317
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sitesOther conditions: Prostatic Neoplasms, Castration-ResistantView official trial listing → -
Completed NCT NCT02616666
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
Not yet reported University of Liverpool 632 participants Est. completion 2025-12-12 132 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02653209
TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.
Not yet reported Royal Devon and Exeter NHS Foundation Trust 525 participants Est. completion 2021-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02678676
An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
Takeda 3599 participants Est. completion 2011-11Type 2 diabetesView official trial listing → -
Completed NCT NCT02683226
Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2015-07 1 siteOther conditions: Polycystic Ovary Syndrome, Insulin ResistanceView official trial listing → -
Completed NCT NCT02689843
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
Not yet reported Shiraz University of Medical Sciences 90 participants Est. completion 2018-12-30 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT02694263
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
Not yet reported University of Leicester 25 participants Est. completion 2018-09-13 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02697617
Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Not yet reported Indiana University 18 participants Est. completion 2020-01 1 siteOther conditions: Polycystic Kidney DiseaseView official trial listing → -
Completed NCT NCT02733679
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Not yet reported NHS Tayside 27 participants Est. completion 2017-08-30 1 siteOther conditions: Ataxia-TelangiectasiaView official trial listing → -
Completed NCT NCT02739750
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Indiana University 35 participants Est. completion 2019-10 1 siteOther conditions: Polycystic Kidney DiseasesView official trial listing → -
Completed NCT NCT02753803
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg
Not yet reported Dong-A ST Co., Ltd. 36 participants Est. completion 2017-03-10 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT02763007
An Extension Study of PEAK Trial
Not yet reported Kun-Ho Yoon 41 participants Est. completion 2019-02-28 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02767063
Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)
Not yet reported, Not yet reported Versailles Hospital 100 participants Est. completion 2023-06 23 sites Stand-aloneOther conditions: Leukemia, Myeloid, Chronic-PhaseView official trial listing → -
Completed NCT NCT02774343
PPARγ Agonist Treatment for Cocaine Dependence
Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 30 participants Est. completion 2015-06 1 siteAlcohol use disorder Other conditions: Cocaine Use DisorderView official trial listing → -
Completed NCT NCT02787551
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Status unknown NCT NCT02823808
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
Not yet reported Kyunghee University Medical Center 96 participants Est. completion 2021-12 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT02852083
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
Not yet reported University Hospital Regensburg 86 participants Est. completion 2020-07 9 sitesOther conditions: Squamous Cell Lung Cancer, Non-Squamous Cell Lung Cancer, Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT02852486
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
Not yet reported University of Campinas, Brazil 31 participants Est. completion 2024-02-07 1 siteOther conditions: Leukemia, Chronic MyeloidView official trial listing → -
Completed NCT NCT02875821
Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone
Not yet reported Yonsei University 44 participants Est. completion 2017-06-07 1 siteMASLDType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT02879409
HbA1c Variability in Type II Diabetes
Not yet reported Weill Cornell Medical College in Qatar 150 participants Est. completion 2026-10-01 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02887625
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
Not yet reported Dr. Muhammad Abdulghani 410 participants Est. completion 2017-05 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT02888964
Pioglityazone and Imatinib for CML Patients
Not yet reported Versailles Hospital 27 participants Est. completion 2016-02 9 sites Stand-aloneOther conditions: Leukemia, Myeloid, Chronic-PhaseView official trial listing → -
Terminated NCT NCT02917629
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2019-08-28 4 sites Stand-aloneOther conditions: Oral Cavity Neoplasm, Oropharyngeal Neoplasm, Stage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7, Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7View official trial listing → -
Completed NCT NCT02919176
Brown Fat Activation Study
Not yet reported Philip Kern 39 participants Est. completion 2019-02-04 1 siteMetabolic syndrome Other conditions: ObeseView official trial listing → -
Terminated NCT NCT02942758
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
Not yet reported University Hospital Regensburg 10 participants Est. completion 2020-03-25 1 siteOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Terminated NCT NCT02989649
Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice
Takeda 593 participants Est. completion 2018-01-26 11 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT03011775
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Not yet reported Ukrainian Medical Stomatological Academy 43 participants Est. completion 2015-09 1 siteOther conditions: Adverse Effect, Atherosclerosis, Coronary, Insulin Resistance SyndromeView official trial listing → -
Completed NCT NCT03030300
Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy
Not yet reported Qianfoshan Hospital 170 participants Est. completion 2015-02 3 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT03060772
A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)
Not yet reported Emory University 50 participants Est. completion 2020-01-28 1 siteOther conditions: AlcoholismView official trial listing → -
Terminated NCT NCT03080480
Pioglitazone Therapy for Chronic Granulomatous Disease
Not yet reported, Not yet reported Children's Hospital of Fudan University 3 participants Est. completion 2019-10-20 1 siteOther conditions: Chronic Granulomatous DiseaseView official trial listing → -
Completed NCT NCT03117517
Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Not yet reported Khyber Medical University Peshawar 106 participants Est. completion 2018-03-07 1 siteOther conditions: Polycystic Ovarian SyndromeView official trial listing → -
Completed NCT NCT03231033
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2019-04-02 1 site Stand-aloneOther conditions: Autoimmune Pulmonary Alveolar ProteinosisView official trial listing → -
Completed NCT NCT03298464
Study of NGM313 in Obese Participants
Not yet reported NGM Biopharmaceuticals, Inc 25 participants Est. completion 2018-07-17 1 siteOther conditions: ObeseView official trial listing → -
Completed NCT NCT03335956
CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
Not yet reported Corcept Therapeutics 48 participants Est. completion 2018-06-25 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT03440034
Study of Pioglitazone in Sporadic Inclusion Body Myositis
Not yet reported Johns Hopkins University 19 participants Est. completion 2020-12-31 1 siteOther conditions: Myositis, Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System DiseasesView official trial listing → -
Withdrawn NCT NCT03452267
Insulin Signaling in Skeletal Muscle
Not yet reported, Not yet reported Wayne State University Est. completion 2025-06Other conditions: Insulin SensitivityView official trial listing → -
Terminated NCT NCT03471117
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
Not yet reported The University of Texas at Arlington 5 participants Est. completion 2020-01-14 2 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT03492580
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 siteType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT03499704
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
Not yet reported Celltrion Pharm, Inc. 133 participants Est. completion 2024-01-16 15 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT03501277
A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants
Not yet reported Takeda 72 participants Est. completion 2018-07-11 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT03566225
Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome
Not yet reported Ain Shams University 400 participants Est. completion 2021-03-30 1 siteOther conditions: PioglitazoneView official trial listing → -
Completed NCT NCT03720366
A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients
Not yet reported Celgene 40 participants Est. completion 2023-12-22 10 sitesOther conditions: Leukemia, Myeloid, AcuteView official trial listing → -
Status unknown NCT NCT03757923
Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism
Not yet reported, Not yet reported Dow University of Health Sciences 110 participants Est. completion 2019-01 1 siteOther conditions: Menstrual Irregularities, HyperandrogenismView official trial listing → -
Status unknown NCT NCT03794518
Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
Not yet reported Hamad Medical Corporation 648 participants Est. completion 2021-12 1 siteOther conditions: Risk ReductionView official trial listing → -
Completed NCT NCT03796975
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease
Not yet reported Xijing Hospital 120 participants Est. completion 2019-11-20 1 siteType 2 diabetes Other conditions: Non-alcoholic Fatty Liver Disease, EfficacyView official trial listing → -
Terminated NCT NCT03860753
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)
Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2019-08-23 1 siteAlcohol use disorderView official trial listing → -
Completed NCT NCT03864146
Pioglitazone for the Treatment of Alcohol Use Disorder
Not yet reported VA Office of Research and Development 201 participants Est. completion 2024-03-29 2 sitesAlcohol use disorderView official trial listing → -
Completed NCT NCT03864523
Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy
Not yet reported Pujol, Aurora, M.D. 18 participants Est. completion 2019-07 2 sitesOther conditions: Adrenomyeloneuropathy, X-linked AdrenoleukodystrophyView official trial listing → -
Active, not recruiting NCT NCT03878459
Dapagliflozin Plus Pioglitazone in T1DM
Not yet reported The University of Texas Health Science Center at San Antonio 120 participants Est. completion 2027-12-31 3 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03910361
Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases
Not yet reported Dong-A ST Co., Ltd. 51 participants Est. completion 2020-07-02 7 sitesType 2 diabetes Other conditions: Non-Alcoholic Fatty Liver DiseaseView official trial listing → -
Status unknown NCT NCT03950505
To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes
Not yet reported Yonsei University 60 participants Est. completion 2020-12 1 site Stand-aloneType 2 diabetes Other conditions: Non-alcoholic SteatohepatitisView official trial listing → -
Completed NCT NCT04013581
Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen
Not yet reported Yonsei University 121 participants Est. completion 2020-05-28 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04027023
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
Not yet reported Sciema UG 9 participants Est. completion 2021-05-31 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT04113889
Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome
Not yet reported Khyber Medical University Peshawar 147 participants Est. completion 2020-01-30 1 siteOther conditions: PCOSView official trial listing → -
Terminated NCT NCT04123067
Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke
Not yet reported, Not yet reported Milton S. Hershey Medical Center 1 participants Est. completion 2021-04-07 1 siteCardiovascular disease Other conditions: Hyperglycemia, DiabetesView official trial listing → -
Status unknown NCT NCT04227093
Acetazolamide Add-On Therapy to OSA Surgery
Not yet reported University Hospital, Antwerp 26 participants Est. completion 2024-08 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT04271189
Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
Not yet reported Azienda Ospedaliero-Universitaria di Parma 108 participants Est. completion 2024-12-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04287387
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2021-03-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04300127
Pioglitazone for Idiopathic Gastroparesis
Not yet reported Johns Hopkins University 14 participants Est. completion 2025-03-18 1 siteOther conditions: GastroparesisView official trial listing → -
Completed NCT NCT04370093
Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss
Not yet reported University of Texas Southwestern Medical Center 29 participants Est. completion 2025-05-28 1 siteOther conditions: Nephrolithiasis, Uric AcidView official trial listing → -
Terminated NCT NCT04416269
Oral Anti Diabetic Agents in the Hospital
Not yet reported Emory University 85 participants Est. completion 2025-04-11 3 sites Added to GLP-1Other conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT04419337
Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke
Not yet reported Chang Gung Memorial Hospital 200 participants Est. completion 2024-01-31 1 siteCardiovascular disease Other conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT04470310
Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
Not yet reported Seoul National University Hospital 99 participants Est. completion 2021-08-31Type 2 diabetesView official trial listing → -
Completed NCT NCT04473274
GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
Not yet reported Samaritan Health Services 10 participants Est. completion 2020-12-01 1 siteOther conditions: Coronavirus Infection, DiabetesView official trial listing → -
Completed NCT NCT04535700
Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19
Not yet reported Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 8 participants Est. completion 2022-01-10 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04584242
Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
Not yet reported Yonsei University 40 participants Est. completion 2022-05 4 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT04604223
Effect of Pioglitazone on T2DM Patients With COVID-19
Not yet reported Dasman Diabetes Institute 1506 participants Est. completion 2021-06-29 5 sitesType 2 diabetes Other conditions: Covid19View official trial listing → -
Completed NCT NCT04657939
Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
Not yet reported University of Leeds 57 participants Est. completion 2022-10-31 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT04658849
Insulin Resistance Following ADT for Prostate CA
Not yet reported St. Louis University Est. completion 2023-03-29 1 siteOther conditions: Insulin Resistance, Prostate CancerView official trial listing → -
Completed NCT NCT04671056
Drug Interaction Study of MGL-3196 With Pioglitazone
Not yet reported Madrigal Pharmaceuticals, Inc. 16 participants Est. completion 2019-01-05 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04794127
Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.
Not yet reported Mario Negri Institute for Pharmacological Research 10 participants Est. completion 2024-09-23 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT04867252
Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome
Not yet reported Khyber Medical University Peshawar 88 participants Est. completion 2021-08-03 1 siteOther conditions: PCOSView official trial listing → -
Completed NCT NCT04885712
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Not yet reported Boryung Pharmaceutical Co., Ltd 378 participants Est. completion 2023-03-10 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04976283
Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
Not yet reported Getz Pharma 123 participants Est. completion 2023-11-15 1 siteType 2 diabetesMASHMASLDView official trial listing → -
Completed NCT NCT04980014
A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea
Takeda 730 participants Est. completion 2019-08-30 8 sitesType 2 diabetesView official trial listing → -
Withdrawn NCT NCT04995978
Insulin Resistance and Androgen Deprivation Therapy
Not yet reported St. Louis University Est. completion 2023-01-18 1 siteOther conditions: Prostate Cancer, Insulin ResistanceView official trial listing → -
Active, not recruiting NCT NCT05040087
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
Not yet reported Foundation for Atlanta Veterans Education and Research, Inc. 127 participants Est. completion 2028-06-30 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT05098327
Pioglitazone and Insulin Resistance in ADT
Not yet reported State University of New York at Buffalo Est. completion 2023-03-31 1 siteType 2 diabetes Other conditions: Prostate Cancer, Insulin Resistance, Androgen DeficiencyView official trial listing → -
Completed NCT NCT05107765
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
Not yet reported, Not yet reported The University of Texas Health Science Center, Houston 67 participants Est. completion 2024-08-16 1 siteAlcohol use disorderView official trial listing → -
Active, not recruiting NCT NCT05220917
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 siteType 2 diabetes Other conditions: Cardiovascular Events, Renal DiseaseView official trial listing → -
Completed NCT NCT05254626
Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis
Not yet reported Cairo University 100 participants Est. completion 2024-07-23 1 siteOther conditions: Non-alcoholic SteatohepatitisView official trial listing → -
Status unknown NCT NCT05394142
A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
Not yet reported Fundació Sant Joan de Déu 364 participants Est. completion 2025-04 7 sitesOther conditions: Polycystic Ovary Syndrome (PCOS)View official trial listing → -
Completed NCT NCT05411965
A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.
Not yet reported Boryung Pharmaceutical Co., Ltd 48 participants Est. completion 2022-07-03 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT05473806
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
Not yet reported Seung Up Kim 28 participants Est. completion 2023-02-19 4 sites Stand-aloneType 2 diabetes Other conditions: Hepatitis B, Chronic, Fibrosis, LiverView official trial listing → -
Status unknown NCT NCT05513729
Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
First Affiliated Hospital Xi'an Jiaotong University 80 participants Est. completion 2024-03-01 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT05519813
Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.
Not yet reported Bing He 60 participants Est. completion 2023-03-20 1 site Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT05521633
Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty Liver
Not yet reported King Edward Medical University 96 participants Est. completion 2022-05-24 1 siteMASLDView official trial listing → -
Terminated NCT NCT05582707
Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
Not yet reported University of Maryland, Baltimore 1 participants Est. completion 2025-12-25 1 siteOther conditions: Intracerebral Haemorrhage, IntraventricularView official trial listing → -
Status unknown NCT NCT05591235
Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 Diabetes
Not yet reported Nanjing First Hospital, Nanjing Medical University 60 participants Est. completion 2023-02Other conditions: Type2diabetes, Insulin ResistanceView official trial listing → -
Status unknown NCT NCT05605158
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Not yet reported Tanta University 56 participants Est. completion 2024-11 1 siteOther conditions: Non Alcoholic SteatohepatitisView official trial listing → -
Status unknown NCT NCT05629806
Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
Not yet reported Nanjing First Hospital, Nanjing Medical University 50 participants Est. completion 2023-05-31 1 siteType 2 diabetes Other conditions: Blood Glucose FluctuationView official trial listing → -
Terminated NCT NCT05659459
The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2
Not yet reported Kinarus AG 17 participants Est. completion 2023-10-01 8 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05760677
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
Not yet reported Affiliated Hospital of Nantong University 142 participants Est. completion 2024-09-30 1 siteType 2 diabetes Other conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesView official trial listing → -
Status unknown NCT NCT05775380
The Role of Pioglitazone in Vascular Transcriptional Remodeling
Not yet reported University of Campinas, Brazil 20 participants Est. completion 2024-12-22 1 siteOther conditions: Myocardial Reperfusion InjuryView official trial listing → -
Completed NCT NCT05813249
Semaglutide in Nonalcoholic Fatty Liver Disease
Not yet reported Zagazig University 180 participants Est. completion 2024-04-01 1 siteOther conditions: Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Not yet recruiting NCT NCT05875675
Effects of Pioglitazone in Calcific Aortic Valve Disease
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 100 participants Est. completion 2028-07-01Other conditions: Calcification of Aortic Valve, Aortic Valve StenosisView official trial listing → -
Active, not recruiting NCT NCT05919147
The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia
Not yet reported Pennington Biomedical Research Center 24 participants Est. completion 2026-06-30 1 siteOther conditions: Lung CancerView official trial listing → -
Status unknown NCT NCT05942963
Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
Not yet reported Jinnah Postgraduate Medical Centre 240 participants Est. completion 2024-04 1 siteOther conditions: Non-Alcoholic Fatty Liver Disease, Type2diabetesView official trial listing → -
Completed NCT NCT06107153
Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control
Not yet reported University of Basrah 243 participants Est. completion 2024-11-01 1 siteOther conditions: Type2diabetesView official trial listing → -
Not yet recruiting NCT NCT06135584
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Not yet reported The Affiliated Hospital of Hangzhou Normal University 1000 participants Est. completion 2026-12-31Other conditions: Metabolic Dysfunction-associated Fatty Liver Disease, CirrhosisView official trial listing → -
Status unknown NCT NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 siteOther conditions: Type2diabetesView official trial listing → -
Not yet recruiting NCT NCT06502249
Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)
Ain Shams University 60 participants Est. completion 2028-09 1 siteOther conditions: Lung Cancer, NSCLCView official trial listing → -
Completed NCT NCT06571591
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
Not yet reported Celltrion 606 participants Est. completion 2026-05-04 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT06594172
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Not yet reported Affiliated Cancer Hospital & Institute of Guangzhou Medical University 67 participants Est. completion 2027-06-30Other conditions: Radiation Disease, Cognitive Impairment, Drug EffectView official trial listing → -
Completed NCT NCT06851962
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Not yet reported Fundación para la Investigación del Hospital Clínico de Valencia 92 participants Est. completion 2026-06-30 3 sitesType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT06922656
Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Not yet reported Dasman Diabetes Institute 60 participants Est. completion 2027-01-15 3 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Not yet recruiting NCT NCT06946628
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
Not yet reported Sun Yat-sen University 296 participants Est. completion 2030-12-31 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT07083232
The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats
Not yet reported Al-Azhar University 50 participants Est. completion 2024-11-30 1 site Stand-aloneCardiovascular disease Other conditions: DiabeticView official trial listing → -
Not yet recruiting NCT NCT07289750
The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD
Not yet reported The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80 participants Est. completion 2027-08-31Type 2 diabetes Other conditions: MAFLDView official trial listing → -
Not yet recruiting NCT NCT07391267
Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
Not yet reported Institute of Liver and Biliary Sciences, India 90 participants Est. completion 2028-12-31 1 siteChronic kidney disease Other conditions: MAFLDView official trial listing → -
Completed NCT NCT07444424
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
Not yet reported AstraZeneca 32 participants Est. completion 2026-07-02 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT07472179
Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS
Not yet reported Mst.Sumyara Khatun 60 participants Est. completion 2026-02-20 1 siteOther conditions: PCOS(Insulin Resistant)View official trial listing → -
Active, not recruiting NCT NCT07604779
Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection
Not yet reported Beni-Suef University 150 participants Est. completion 2027-03-03 1 siteOther conditions: Polycystic Ovarian Syndrome (PCOS)View official trial listing → -
Not yet recruiting NCT NCT07635953
New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
Not yet reported Sun Yat-sen University 296 participants Est. completion 2031-07-01 1 siteOther conditions: Diabetes MellitusView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Pioglitazone Hydrochloride, Actos
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.